Cullinan Therapeutics annual total assets
2020
2021
2022
2023
2024
2025
Cullinan Therapeutics Total Assets Growth & History (CGEM)
Cullinan Therapeutics's total assets was $448.4M for fiscal 2025.
View full Cullinan Therapeutics company overviewCullinan Therapeutics annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $448.4M | −$173.4M | −27.89% |
| 2024 | 2024-12-31 | $621.8M | $137.6M | +28.43% |
| 2023 | 2023-12-31 | $484.2M | −$76.9M | −13.71% |
| 2022 | 2022-12-31 | $561.1M | $123.9M | +28.35% |
| 2021 | 2021-12-31 | $437.2M | $222.5M | +103.62% |
| 2020 | 2020-12-31 | $214.7M | — | — |
Cullinan Therapeutics quarterly total assets
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $363.8M | −$156.5M | −30.09% |
| Q1 2026 | 2026-03-31 | $403.0M | −$176.7M | −30.48% |
| Q4 2025 | 2025-12-31 | $448.4M | −$173.4M | −27.89% |
| Q3 2025 | 2025-09-30 | $484.1M | −$169.1M | −25.89% |
| Q2 2025 | 2025-06-30 | $520.3M | −$160.9M | −23.62% |
| Q1 2025 | 2025-03-31 | $579.7M | $130.3M | +28.98% |
| Q4 2024 | 2024-12-31 | $621.8M | $137.6M | +28.43% |
| Q3 2024 | 2024-09-30 | $653.3M | $158.5M | +32.05% |
| Q2 2024 | 2024-06-30 | $681.2M | $159.2M | +30.51% |
| Q1 2024 | 2024-03-31 | $449.4M | −$65.6M | −12.73% |
| Q4 2023 | 2023-12-31 | $484.2M | −$76.9M | −13.71% |
| Q3 2023 | 2023-09-30 | $494.7M | −$122.5M | −19.85% |
| Q2 2023 | 2023-06-30 | $522.0M | −$145.3M | −21.77% |
| Q1 2023 | 2023-03-31 | $515.0M | $77.5M | +17.72% |
| Q4 2022 | 2022-12-31 | $561.1M | $123.9M | +28.35% |
| Q3 2022 | 2022-09-30 | $617.2M | $163.8M | +36.13% |
| Q2 2022 | 2022-06-30 | $667.2M | $202.9M | +43.69% |
| Q1 2022 | 2022-03-31 | $437.5M | −$42.2M | −8.80% |
| Q4 2021 | 2021-12-31 | $437.2M | $222.5M | +103.62% |
| Q3 2021 | 2021-09-30 | $453.4M | — | — |
| Q2 2021 | 2021-06-30 | $464.4M | — | — |
| Q1 2021 | 2021-03-31 | $479.7M | — | — |
| Q4 2020 | 2020-12-31 | $214.7M | — | — |
Cullinan Therapeutics total assets trends
Over the last five fiscal years, Cullinan Therapeutics's total assets increased from $214.7M to $448.4M, a change of $233.7M. The latest reported quarter, Q2 2026, shows $363.8M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cullinan Therapeutics source filings ↗